© Oxford University Press, 2004.
Editorial |
Equivalence and Non-inferiority Trials of CAM
Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, Exeter, UK
| The first 10% of the full text of this article appears below. |
For several reasons, the value of placebo-controlled trials has often been disputed (not only) in complementary/alternative medicine (CAM) (1). Many clinicians feel that giving placebos to suffering patients is unethical. In fact, the Declaration of Helsinki advocates placebo-controlled trials only for conditions for which no therapy of proven efficacy exists (2). Other frequently cited reasons against the use of placebos in controlled clinical trials include the notions that patients find them hard to accept, that the placebo effect is an important contributor to the overall therapeutic effect, which should be cultivated rather than eliminated, and that placebo effects
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. R. Milgrom Journeys in The Country of The Blind: Entanglement Theory and The Effects of Blinding on Trials of Homeopathy and Homeopathic Provings Evid. Based Complement. Altern. Med., March 1, 2007; 4(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bellavite, R. Ortolani, F. Pontarollo, V. Piasere, G. Benato, and A. Conforti Immunology and Homeopathy. 4. Clinical Studies--Part 1 Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kaphle, L.-S. Wu, N.-Y. J. Yang, and J.-H. Lin Herbal medicine research in taiwan*. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 149 - 155. [Abstract] [Full Text] [PDF] |
||||
